These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24345539)

  • 1. Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats.
    Himeno K; Seike M; Fukuchi S; Masaki T; Kakuma T; Sakata T; Yoshimatsu H
    Obes Res Clin Pract; 2009 Mar; 3(1):1-52. PubMed ID: 24345539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats.
    Raju J; Bird RP
    Int J Obes (Lond); 2006 Aug; 30(8):1298-307. PubMed ID: 16477270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fatty (fa) allele and high-fat diet on adipose tissue leptin and lipid metabolism.
    Heo YR; Claycombe K; Jones BH; Wright P; Truett GE; Zemel M; Banz W; Maher M; Moustaid-Moussa N
    Horm Metab Res; 2002; 34(11-12):686-90. PubMed ID: 12660883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin production by the stomach is up-regulated in obese (fa/fa) Zucker rats.
    Picó C; Sánchez J; Oliver P; Palou A
    Obes Res; 2002 Sep; 10(9):932-8. PubMed ID: 12226142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats.
    Al-Barazanji KA; Arch JR; Buckingham RE; Tadayyon M
    Obes Res; 2000 Jul; 8(4):317-23. PubMed ID: 10933308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
    Yang YY; Tsai TH; Huang YT; Lee TY; Chan CC; Lee KC; Lin HC
    Hepatology; 2012 May; 55(5):1540-50. PubMed ID: 22183953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of exercise on circulating leptin in lean and genetically obese fa/fa rats.
    Pagano C; Marzolo M; Granzotto M; Ricquier D; Federspil G; Vettor R
    Biochem Biophys Res Commun; 1999 Feb; 255(3):698-702. PubMed ID: 10049773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure.
    Goh TT; Mason TM; Gupta N; So A; Lam TK; Lam L; Lewis GF; Mari A; Giacca A
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E549-60. PubMed ID: 17003242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.
    Davis LM; Michaelides M; Cheskin LJ; Moran TH; Aja S; Watkins PA; Pei Z; Contoreggi C; McCullough K; Hope B; Wang GJ; Volkow ND; Thanos PK
    Neuroendocrinology; 2009; 89(2):152-62. PubMed ID: 18984941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of bone structure in leptin receptor-deficient Zucker (fa/fa) rats.
    Tamasi JA; Arey BJ; Bertolini DR; Feyen JH
    J Bone Miner Res; 2003 Sep; 18(9):1605-11. PubMed ID: 12968669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats.
    Enriquez A; Leclercq I; Farrell GC; Robertson G
    Biochem Biophys Res Commun; 1999 Feb; 255(2):300-6. PubMed ID: 10049703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats.
    Gillam M; Noto A; Zahradka P; Taylor CG
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):331-9. PubMed ID: 19864121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphagia as a mediator of renal disease initiation in obese Zucker rats.
    Stevenson FT; Wheeldon CM; Gades MD; van Goor H; Stern JS
    Obes Res; 2001 Aug; 9(8):492-9. PubMed ID: 11500530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone responses to body weight and moderate treadmill exercising in growing male obese (fa/fa) and lean Zucker rats.
    Ip TY; Peterson J; Byrner R; Tou JC
    J Musculoskelet Neuronal Interact; 2009; 9(3):155-66. PubMed ID: 19724150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA.
    Hardie LJ; Rayner DV; Holmes S; Trayhurn P
    Biochem Biophys Res Commun; 1996 Jun; 223(3):660-5. PubMed ID: 8687452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats.
    Noto A; Zahradka P; Ryz NR; Yurkova N; Xie X; Taylor CG
    Metabolism; 2007 Jan; 56(1):142-51. PubMed ID: 17161237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo.
    Fishman S; Muzumdar RH; Atzmon G; Ma X; Yang X; Einstein FH; Barzilai N
    FASEB J; 2007 Jan; 21(1):53-60. PubMed ID: 17099068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.